Trademark: 90677316
Status Date
Monday, June 12, 2023
Filing Date
Wednesday, April 28, 2021
Published for Opposition
Tuesday, November 8, 2022
Abandoned Date
Monday, June 12, 2023
42 pharmaceutical drug product development; facilitating clinical trials, namely, Scientific research in the nature of conducting clinical trials for others
Jun 12, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
Jun 12, 2023
Abandonment - After Inter Partes Decision
Jun 12, 2023
Opposition Terminated No. 999999
Jun 12, 2023
Opposition Sustained No. 999999
Mar 7, 2023
Opposition Instituted No. 999999
Dec 2, 2022
Extension Of Time To Oppose Received
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 6, 2022
Approved For Pub - Principal Register
Oct 6, 2022
Examiner's Amendment Entered
Oct 6, 2022
Notification Of Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment E-Mailed
Oct 6, 2022
Examiners Amendment -Written
Aug 15, 2022
Teas/Email Correspondence Entered
Aug 15, 2022
Correspondence Received In Law Office
Aug 15, 2022
Teas Response To Office Action Received
Feb 14, 2022
Notification Of Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action E-Mailed
Feb 14, 2022
Non-Final Action Written
Dec 27, 2021
Assigned To Examiner
Aug 2, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
